A Morpholino Oligomer Targeting Highly Conserved Internal Ribosome Entry Site Sequence Is Able To Inhibit Multiple Species of Picornavirus
- 1 June 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (6) , 1970-1981
- https://doi.org/10.1128/aac.00011-08
Abstract
Members of the genera Enterovirus and Rhinovirus (family Picornaviridae) cause a wide range of human diseases. An established vaccine is available only for poliovirus, and no effective therapy is available for the treatment of infections caused by any pathogenic picornavirus. Peptide-conjugated phosphorodiamidate morpholino oligomers (PPMO) are single-stranded DNA-like antisense agents that readily enter cells. A panel of PPMO was tested for their antiviral activities against various picornaviruses. PPMO targeting conserved internal ribosome entry site (IRES) sequence were highly active against human rhinovirus type 14, coxsackievirus type B2, and poliovirus type 1 (PV1), reducing PV1 titers by up to 6 log(10) in cell cultures. Comparative sequence analysis led us to design a PPMO (EnteroX) targeting 22 nucleotides of IRES sequence that are perfectly conserved across greater than 99% of all human enteroviruses and rhinoviruses. EnteroX reduced PV1 replication in cell culture to an extent similar to that of other IRES-specific PPMO. Resistant PV1 arose in cell cultures after 12 passages in the presence of EnteroX and were found to have two mutations within the EnteroX target sequence. Nevertheless, cPVR transgenic mice treated once daily by intraperitoneal (i.p.) injection with EnteroX before and/or after i.p. infection with 3 x 10(8) PFU (three times the 50% lethal dose) of PV1 had an approximately 80% higher rate of survival than the controls. The viral titer in tissues taken at day 5 postinfection showed that animals in the EnteroX-treated group averaged over 3, 4, and 5 log(10) less virus in the small intestine, spinal cord, and brain, respectively, than the amount in the control animals. These results suggest that EnteroX may have broad therapeutic potential against entero- and rhinoviruses.Keywords
This publication has 62 references indexed in Scilit:
- The Picornavirus Avian Encephalomyelitis Virus Possesses a Hepatitis C Virus-Like Internal Ribosome Entry Site ElementJournal of Virology, 2008
- Inhibition of Foot-and-Mouth Disease Virus Infections in Cell Cultures with Antisense Morpholino OligomersJournal of Virology, 2007
- In Vitro Resistance Selection and In Vivo Efficacy of Morpholino Oligomers against West Nile VirusAntimicrobial Agents and Chemotherapy, 2007
- Antiviral Effects of Antisense Morpholino Oligomers in Murine Coronavirus Infection ModelsJournal of Virology, 2007
- Inhibition of Coxsackievirus B3 in Cell Cultures and in Mice by Peptide-Conjugated Morpholino Oligomers Targeting the Internal Ribosome Entry SiteJournal of Virology, 2006
- Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino OligomersAntimicrobial Agents and Chemotherapy, 2006
- Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich PeptidesBioconjugate Chemistry, 2004
- Impaired Binding of Standard Initiation Factors Mediates Poliovirus Translation AttenuationJournal of Virology, 2003
- Genetic studies on the poliovirus 2C protein, an NTPase A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerizationJournal of Molecular Biology, 1994
- The pathogenesis of poliomyelitis. Sites of multiplication of poliovirus in cynomolgus monkeys after alimentary infectionArchiv für die gesamte Virusforschung, 1960